This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This protocol is designed to test the safety of a vaccine consisting of five ovarian cancer-associated peptides in adjuvant in patients with Stage III or IV ovarian cancer. This study will also gather preliminary data on the immunogenicity of the peptides. Immune responses will be measured in the peripheral blood using the ELIspot assay.
Showing the most recent 10 out of 674 publications